Clinical Trial Update: The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety results for PRC-4016 in hypertriglyceridemic subjects. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertriglyceridemia

Drugs mentioned

• PRC-4016

Snippet

Sponsor: Pronova BioPharma | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED